Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers; focus on pathological mechanisms-Reference-Cited by-同舟云学术

Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers; focus on pathological mechanisms

Published:2024-01 Issue: Volume: Page:155119
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Jasim Saade Abdalkareem,Majeed Ali A.,Uinarni Herlina,Alshuhri Mohammed,Alzahrani Abdullah Ali,Ibrahim Abeer A.,Alawadi Ahmed,Abed Al-Abadi Noor K.,Mustafa Yasser Fakri,Ahmed Batool Ali

Publisher

Elsevier BV

Reference167 articles.

1. Cancer statistics, 2022. CA. 506;Siegel;Cancer J Clin.,2022

2. The functions and unique features of long intergenic non-coding RNA;Ransohoff;Nature reviews Molecular cell biology,2018

3. The functions and unique features of LncRNAs in cancer development and tumorigenesis;Taniue;International journal of molecular sciences,2021

4. LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside;Hu;Cell Death Discovery,2022

5. H19 lncRNA: roles in tumorigenesis;Ghafouri-Fard;Biomedicine & Pharmacotherapy.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific small interfering RNAs (siRNAs) for targeting the metastasis, immune responses, and drug resistance of colorectal cancer cells (CRC);International Immunopharmacology;2024-10

2. LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review;Cytokine;2024-07

3. Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells;Cancers;2024-04-29